ICYMI 2021 Rheumatology Year In Review

Jul 08, 2022 2:48 pm
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021. My Top 10 list 1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod 2. New FDA Indications 3. New Biologics for Lupus 4. Super "H" Hydroxychloroquine 5. Zoomatology 6. Avacopan 7. Tocilizumab 8. FDA & JAK inhibitor warnings 9. New Biologics for GCA 10. IL-23 Inhibitors https://rheumnow.com/news/2021-rheumatology-year-review-172022

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Subscribe and Rate

Subscribe to the RheumNow podcast on your favorite podcast app to get automatic downloads of the latest content. Listen in the car, airplane, anywhere! We also reach more listeners through reviews from our users. Consider leaving a review!
 

 

×